Cross-Border Impact Ventures is a women-led impact venture capital firm based in Toronto that invests in health technology companies addressing the needs of women, children, and adolescents globally. The firm's first fund closed with over $90 million USD in commitments.
56% of their portfolio is in Healthcare. Their most common stage is series-a (56% of deals). Average disclosed round size is $15.2M (across 9 rounds with reported amounts).
Portfolio
9
Fund Size
$90M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOxford Cancer Analytics (OXcan) | Series A | $11M | Jan 2025 |
| OOXcan | Series A | $11M | Jan 2025 |
 Oncolens | Series B | $16M | Oct 2024 |
 Raydiant Oximetry | Series A | $7.5M | Jun 2024 |
 Sonio | Series A | $14M | Aug 2023 |
 Pendulum | Unknown | $22M | — |
 Oxford Cancer Analytics | Series A | $11M | — |
 Pendulum Systems | Unknown | $22M | — |
 Pendulum | Unknown | $22M | — |
Top Co-Investors
Lowercarbon Capital3 shared
Decisive Point3 shared
Macmillan Cancer Support2 shared
Civilization Ventures2 shared
RH Capital1 shared
DCVC1 shared
Plug and Play Tech Center1 shared
Martin Ventures1 shared
OneRagtime1 shared
Elaia1 shared
We Venture Capital1 shared
OKG Investments1 shared
Bek Ventures1 shared
Digitalis Ventures1 shared
Last updated: 20 October 2026